Two Sigma Securities, LLC Immunity Bio, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $12,030 - $50,141	9,624 Added 28.32%	43,604 $218,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $3.1 $43,834 - $105,338	33,980 New	33,980 $57,000
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $15,765 - $55,820	11,678 New	11,678 $21,000
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $108,545 - $248,682	-40,502 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $204,535 - $304,980	40,502 New	40,502 $227,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.